SR
MRK icon

Syntax Research’s Merck MRK Stock Holding History

Syntax Research’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$177K Hold
1,381
– – 0.13% 58
2026
Q1 		$166K Sell
1,381
-3,435
-71% -$397K 0.11% 69
2025
Q4 		$507K Buy
4,816
+9
+0.2% +$845 0.31% 55
2025
Q3 		$403K Buy
4,807
+801
+20% +$66K 0.26% 60
2025
Q2 		$317K Sell
4,006
-30,028
-88% -$2.39M 0.23% 57
2025
Q1 		$3.05M Buy
34,034
+719
+2% +$67.1K 2.11% 18
2024
Q4 		$3.31M Buy
33,315
+21,140
+174% +$2.18M 2.38% 14
2024
Q3 		$1.38M Buy
12,175
+10,000
+460% +$1.19M 0.93% 33
2024
Q2 		$269K Hold
2,175
– – 0.21% 52
2024
Q1 		$287K Hold
2,175
– – 0.22% 55
2023
Q4 		$237K Hold
2,175
– – 0.2% 55
2023
Q3 		$224K Buy
+2,175
New +$234K 0.18% 55

Other funds holding MRK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Syntax Research's MRK Position: Q2 2026 in Review

Syntax Research held its Merck (MRK) position steady in Q2 2026 at 1,381 shares worth $177K. The position accounts for 0.13% of the portfolio, ranked #58.

Syntax Research first reported a position in MRK in Q3 2023 and has held it in 12 quarters since. The position peaked at $3.31M in Q4 2024. 3,818 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Syntax Research held 1,381 shares of Merck worth $177K as of Q2 2026.
  • Syntax Research left its Merck share count unchanged in Q2 2026.
  • Merck made up 0.13% of Syntax Research's portfolio in Q2 2026, its #58 holding.
  • Syntax Research first reported a position in Merck in Q3 2023 and has held it in 12 quarters since.
  • Syntax Research's Merck position peaked at $3.31M in Q4 2024.
  • 3,818 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Syntax Research's 13F filing for Q2 2026, filed 31 Jul 2026.